NDC 50090-5029

INVOKANA

Canagliflozin

INVOKANA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Canagliflozin.

• Product ID: 50090-5029_203d1037-eed8-4248-a748-1d4f5555b4d1
• NDC: 50090-5029
• Product Type: Human Prescription Drug
• Proprietary Name: INVOKANA
• Generic Name: Canagliflozin
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2013-03-29
• Marketing Category: NDA / NDA
• Application Number: NDA204042
• Labeler Name: A-S Medication Solutions
• Substance Name: CANAGLIFLOZIN
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 50090-5029-0

90 TABLET, FILM COATED in 1 BOTTLE (50090-5029-0)

• Marketing Start Date: 2020-04-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "INVOKANA" or generic name "Canagliflozin"

NDC	Brand Name	Generic Name
50090-4364	INVOKANA	canagliflozin
50090-5029	INVOKANA	canagliflozin
50090-5033	INVOKANA	canagliflozin
50090-5034	INVOKANA	canagliflozin
50458-140	INVOKANA	canagliflozin
50458-141	INVOKANA	canagliflozin
55154-1425	INVOKANA	canagliflozin
55154-1426	INVOKANA	canagliflozin